Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKPTEC: 12-h vs 2-h Urokinase in Pulmonary Thromboembolism
NCT00799968Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Jun 2002
- Primary completion
- Feb 2006
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of urokinase in pulmonary thromboembolism (PE) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoints: Improvement of the right ventricular function at 14 days and Perfusion defect score on lung V/Q scans or CTPA score at 14 days. Started Jun 2002; status: completed.
02
Drugs
urokinase
03
Conditions
pulmonary thromboembolism (PE)
Beyond the preview
Go deeper on NCT00799968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799968.